|
⚲
|
| Keyboard |
| Cimarron Healthcare Capital LLC
✚
|
|
|---|---|
| CRD # | 282387 |
| SEC # | 801-126250 |
| CIK # | |
| AUM | 532.7 M (2026-03-26) |
| Employees | 7 (100% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 801-849-9293 |
| Address | 6440 S Wasatch Blvd Salt Lake City, UT 84121 |
| Source | [IAPD] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/26/2026) [Brochure] |
|---|
Item 5. Fees and Compensation The fees and expenses that are applicable to an investment are set forth and agreed to in each Client’s governing documents, which may include a private offering memorandum, limited partnership agreement, subscription and operating agreement, and investment management agreement or other agreements (collectively, the “Offering Documents”). Investors and prospective investors must carefully review the Offering Documents of the Client in which they are invested or may invest, to review the specific fees and expenses applicable to their investment. The Adviser or any of its respective affiliates, shall have the right to contract for and receive management fees (based on a percentage of assets under management) from the Clients in connection with the activities of the Adviser. The terms of these fees range among the Clients, and the details for each Client are set forth in the relevant Offering Documents. Whether these fees are paid in arrears or in advance is determined by the investment terms applicable to a specific Client and set forth in its Offering Documents. The Adviser and its affiliates and their respective employees have received certain of the following fees and may in the future receive, transaction, consulting, advisory, directors’, monitoring, break-up or similar fees associated with investments or prospective portfolio investments or commitments made by a Fund (“Other Fees”). Generally, a Fund’s share of such Other Fees will first be used to pay unreimbursed related expenses, and, thereafter, 100% of each limited partner’s pro rata share (generally determined in accordance with commitments, or funded commitments, as applicable) of any such remaining Other Fees received by the Adviser or any of its affiliates will be applied to reduce, on a dollar for dollar basis, future payments of the management fee in respect of such limited partner (but not below zero). Cimarron has, and may in the future, in its sole discretion, waive or modify management fees (and performance fees as described below) for affiliates, operating partners, members or employees of the Firm of certain clients’ general partners. In addition, expenses incurred by the Adviser or its affiliates in connection with proposed or actual portfolio investments in, or the provision of services to, portfolio companies have been, and may continue to, be reimbursed by such portfolio companies rather than being borne by the Adviser or a Fund, as applicable. In the event the aggregate amount of such Other Fees applied against the management fee during a fiscal year exceeds the management fee for such fiscal year, the excess will be carried forward to reduce the next payment(s) of the management fee. Subject to the terms of the relevant Client’s Offering Documents, generally, the Client shall pay for any and all expenses, costs and liabilities incurred by the Client including but not limited to: (a) the organization and maintenance of any alternative investment vehicle, holding vehicle, blocker corporation or underlying partnership, including documentation related thereto; (b) all expenses, costs and liabilities incurred in connection with the identifying, evaluating, structuring, negotiating, making, acquiring, holding, monitoring, sale, proposed sale, other disposition or valuation of portfolio investments and temporary investments or prospective portfolio investments and temporary investments (including due diligence in connection therewith), including, but not limited to, legal, administrative, research, due diligence, accounting, consulting, audit, travel (which, in the case of air travel, may be first or business class or, under certain limited circumstances, charter travel), lodging (which may include luxury class accommodations), meals (including meals with portfolio company or prospective portfolio company management), entertainment, investment banking fees, other professional fees, underwriting commissions and discounts, research expenses and other investment costs and expenses incurred in connection with the employment of any selling agent, broker, placement agent or finder (other than placement agent fees payable in connection with the sale of interests in such Client) and the attendance at conferences in connection with the evaluation of future investments or specific sectors or industries solely to the extent that such conferences are in furtherance of such Client’s business; (c) all expenses and costs incurred as a result of a proposed transaction or investment by such Client that is not consummated, to the extent not reimbursed by a third party, including (i) break-up fees paid by such Client in connection therewith, (ii) fees associated with researching such proposed transaction or investment (including third party advisor fees, travel, lodging, meals and entertainment) and (iii) expenses and costs related to unconsummated co-investments that would have been allocable to co-investors had such proposed transaction or investment been consummated, if the amount allocable to such co-investors is not paid by such parties; (d) indemnification and insurance expenses, including indemnification expenses associated with service providers, the costs and expenses of any litigation (including damages), investigation or reviews or other extraordinary events involving such Client, D&O liability, professional liability and other insurance and indemnity expenses, including the amount of any judgments or settlements paid in connection therewith; (e) all taxes, interest, fees and other governmental or regulatory charges (including any penalties thereon) levied against such Client, except to the extent such amounts are (i) allocable to or indemnifiable by an investor and (ii) actually borne or paid by such investor; (f) expenses incidental to the transfer, servicing and accounting for such Client’s cash and ... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/26/2026) [Brochure] |
|---|
Item 7. Types of Clients As described in Item 4, Cimarron provides investment management services to private fund Clients. Investors in these vehicles include or may in the future include (but are not/will not be limited to): • individuals; • pension and profit sharing plans (domestic and foreign); • segregated accounts formed by insurance companies; • family offices; • trusts, estates, charitable organizations, foundations and endowments; and • limited liability companies and corporations. |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | PV365 Co-Invest LP | [2024-03-27] | 27.1 M | |
| Filed 2023-04-21 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Cimarron Continuation Fund LP | [2022-03-31] | 178.1 M | |
| Filed 2021-03-19 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $1,130,000 · Revenue Decline to Disclose | ||||
| PE | Cimarron Healthcare Capital Fund II-A LP | 2022-03-31 | 2.4 M | |
| PE | Cimarron Healthcare Capital Fund II-B LP | [2022-03-31] | 118.7 M | 7.9 M |
| Filed 2023-02-06 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $3,500,000 · Revenue Decline to Disclose | ||||
| PE | Cimarron Healthcare Capital Fund II LP | [2022-03-31] | 118.7 M | 141.6 M |
| Filed 2023-02-06 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $3,500,000 · Revenue Decline to Disclose | ||||
| PE | Olympus Ascent Investors LLC | [2021-03-29] | 11.5 M | 16.5 M |
| Offered $11,495,832 · Filed 2020-03-13 (D) · Exemption 506(b), 3(c)(1), 3(c) · Minimum $63,750 · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Cimarron Healtchare Investments II LP | [2017-03-27] | 1.0 M | 1.6 M |
| Offered $2,000,000 · Filed 2015-07-06 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $1,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Cimarron Healthcare Investments I LP | [2016-01-04] | 4.0 M | 150.9 M |
| Offered $50,000,000 · Filed 2015-07-06 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $46,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 7 | 532.7 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 8 | 532.7 |
| By Discretionary | ||
| Discretionary | 8 | 532.7 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 532.7 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 532.7 | |
| Total | 8 | 532.7 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Robert Adelson | Executive Officer | 25 | 5 | |
| James Nadauld | Executive Officer | 12 | 2 | |
| Clay Andrus | Executive Officer | 1 | 1 | |
| Olympus Ascent GP LLC | Director | 1 | 1 |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
K Fund Capital Management LLC
✚
|
CA | 539.3 M |
|
BP Capital Energy Advisors LLC
✚
|
TX | 537.2 M |
|
Juniper Capital Advisors LP
✚
|
TX | 535.4 M |
|
Sky Island Capital LP
✚
|
TX | 533.5 M |
|
New Silk Route Advisors LP
✚
|
NY | 531.5 M |
|
Cap91 Partners Management LLC
✚
|
VA | 531.0 M |
|
Securitize Capital LLC
✚
|
FL | 530.2 M |
|
A-Street Management LP
✚
|
530.0 M | |
|
Archean Capital Partners II LLC
✚
|
PA | 527.8 M |
|
One Bow River Advisers LLC
✚
|
CO | 525.9 M |